BRCA2 and breast cancer: Differences in breast tumor hormone receptor status suggest that TH cases developing BC have an intermediate cancer phenotype between BRCA1 and BRCA2, which would be consistent with the tumors being driven by loss of either BRCA1 or BRCA2. We attempted to determine the frequency of loss of each gene in a subset of cases where tumor material was available.